1.68BMarket Cap-38.65P/E (TTM)
23.630High23.010Low363.12KVolume23.230Open23.410Pre Close8.43MTurnover1.56%Turnover RatioLossP/E (Static)72.64MShares28.15052wk High3.84P/B539.21MFloat Cap16.56052wk Low--Dividend TTM23.25MShs Float32.880Historical High--Div YieldTTM2.65%Amplitude5.010Historical Low23.212Avg Price1Lot Size
Kiniksa Pharmaceuticals International Stock Forum
Can Kiniksa's 79% Revenue Surge Continue as Company Shifts Pipeline Focus?
$Regenxbio (RGNX.US)$ Phase 2
$Leap Therapeutics (LPTX.US)$ Phase 2
$4D Molecular Therapeutics (FDMT.US)$ Phase 2
$Adverum Biotechnologies (ADVM.US)$ Phase 2
$Denali Therapeutics (DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals (EYPT.US)$ Phase 2
$Xencor (XNCR.US)$ Phase 2
$Harmony Biosciences (HRMY.US)$ Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$ Phase 2
$Disc Medicine (IRON.US)$ Phase 2
$Atea Pharmaceuticals (AVIR.US)$ Phase 2
$Allakos (ALLK.US)$ Phase 2 ...
i) Current market- $SPDR S&P 500 ETF (SPY.US)$
ii) Oil price
iii) My trade based on stage analysis
i) To be honest, after the last month CPI showed that the inflation is still not under controlled, the big sell off volume ha...
No comment yet